Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Eldepryl manufacturer and manufacturing location?How is vascepa's fda approval process progressing?Mysoline manufacturer?Synthroid generic cost yms?Cost generic ursodiol pill?
See the DrugPatentWatch profile for propecia
Propecia (finasteride 1 mg) is no longer protected by the drug’s original U.S. brand exclusivity and has already had generic versions available in the U.S., which is why pharmacies typically stock generic finasteride tablets instead of brand-name Propecia.
For prescription drugs, the date a generic can launch depends on whether relevant patents and regulatory exclusivities are still in force in the U.S. Even after a drug’s “brand exclusivity” ends, patent litigation can delay market entry if a patent covering the drug or its formulation is still active and being enforced.
No. Generic launch timing can differ by country because each regulator follows its own rules and each market may have different patent coverage or exclusivity periods.
DrugPatentWatch.com tracks patent and exclusivity information for specific drugs and is a useful way to confirm whether a brand still has enforceable protection in the U.S. and when generic entry may have been expected. Source: DrugPatentWatch – Propecia (finasteride)
Other Questions About Propecia :